As a provider of bespoke services for the discovery of dynamic biomarkers, Sapient leverages its high throughput, untargeted lipidomics and metabolomics approaches to probe deeper into the human lipidome and metabolome at a rate is unmatched for discovery. Our mass spectrometry-based lipidomics methods lead the market in speed and scalability, enabling us to rapidly uncover both known and unknown lipid biomarkers that associate with early disease, disease progression, and drug response.
By pairing nontargeted data generation with advanced lipidomics data analysis, including lipidomics pathway analysis, we help identify robust biomarkers to elucidate lipid function and disease biology, enrich clinical trials, and align patients, disease, and precision therapies. How does it work?
Learn more about why Sapient is the choice lipidomics lab for novel biomarker discovery, and how we can work together to advance your drug programs at any phase. Use the sidebar to download additional details or request services directly.
See the breadth of chemistries captured across 15K+ molecules, including polar metabolites and polar and nonpolar lipids.
"(Required)" indicates required fields
You can schedule a meeting to discuss details and turnaround time using the link below.